Successful A2 to O Simultaneous Liver and Kidney Transplantation in the Setting of Pre-operative Positive HLA Crossmatch: A Case Report
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.05.017 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Mythili Vigneshwar und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Virginia Commonwealth University, Richmond, Virginia. Hauptthemen laut MEDLINE: HLA Antigens, Kidney Transplantation, Liver Transplantation. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Simultaneous liver and kidney transplantation (SLKT) is possible for patients with high donor-specific HLA antibodies or with A2 donors to O recipients with high A2 titers. We report the first case of SLKT in a highly sensitized O recipient with organs from an A2 donor. The recipient is a 59-year-old woman with chronic kidney disease and liver failure due to autoimmune hepatitis and drug-induced liver injury. Immune work-up 8 days pre-transplant demonstrated a negative crossmatch and no HLA antibody (calculated panel reactive antibodies = 0%). Anti-A2 IgG levels were 512. The donor was a deceased 24-year-old man. One day before transplantation, serum from the recipient showed a significant increase in antibody reactivity (calculated panel reactive antibodies = 100%) attributable to blood product transfusion and memory response from previous pregnancies. Consequently, a crossmatch was positive for T and B cells with two newly detected HLA antibodies against the donor's antigens. On the day of surgery, the liver was transplanted first. Six hours and 37 minutes later, a repeat flow crossmatch was negative; donor-specific antibodies (DSAs) fell below the positive threshold, and anti-A2 IgG titer fell to 256. Thus, the kidney was transplanted after basiliximab induction therapy. Seven days post-transplant, non-donor-specific HLA antibodies were present but DSAs remain negative. The patient was discharged on postoperative day 57 with no signs of rejection at 4 months. This case illustrates a rapid and prolonged reduction in antibody titers (HLA and ABO) after SLKT. SLKT is feasible in patients with both DSA and high anti-A2 titer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, Virginia Commonwealth University, Richmond, Virginia.
- Department of Surgery, Division of Transplant Surgery, Hume- Lee Transplant Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia. Electronic address: Yuzuru.Sambommatsu@vcuhealth.org.
- Department of Internal Medicine, Division of Nephrology, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
- Department of Surgery, Division of Transplant Surgery, Hume- Lee Transplant Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
Zitieren
APA
Vigneshwar, M., Sambommatsu, Y., Gupta, G., Philogene, M. C., & Bruno, D. A. (2024). Successful A2 to O Simultaneous Liver and Kidney Transplantation in the Setting of Pre-operative Positive HLA Crossmatch: A Case Report. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.05.017
Vancouver
Vigneshwar M, Sambommatsu Y, Gupta G, Philogene MC, Bruno DA. Successful A2 to O Simultaneous Liver and Kidney Transplantation in the Setting of Pre-operative Positive HLA Crossmatch: A Case Report. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.05.017
BibTeX
@article{Vigneshwar2024,
author = {Vigneshwar, Mythili and Sambommatsu, Yuzuru and Gupta, Gaurav and Philogene, Mary Carmelle and Bruno, David A},
title = {Successful A2 to O Simultaneous Liver and Kidney Transplantation in the Setting of Pre-operative Positive HLA Crossmatch: A Case Report},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.05.017}
}
EUVIMED